Patent · US Active

siRNA targeting carbonic anhydrase II

US7579457B2 · kind B2 · utility

70Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 7, 2006
Grant dateAug 25, 2009
Priority date
Expiry dateMar 22, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/11
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.